Jinyu Bio-Technology Co (SHSE:600201) Other Current Payables: ¥238 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600201 Jinyu Bio-Technology Co Ltd SHSE:600201
65 GF Score
Price ¥11.30
GF Value ¥8.34
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Jinyu Bio-Technology Co Other Current Payables?

Jinyu Bio-Technology Co SHSE:600201 -1.82% 65 Other Current Payables is ¥238 Mil as of Mar. 2026. GuruFocus rates SHSE:600201 with a GF Score™ of 65/100 and a GF Value™ of ¥8.34 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Jinyu Bio-Technology Co's Other Current Payables for the quarter that ended in Mar. 2026 was ¥238 Mil.

Jinyu Bio-Technology Co's quarterly Other Current Payables increased from Sep. 2025 (¥317 Mil) to Dec. 2025 (¥335 Mil) but then declined from Dec. 2025 (¥335 Mil) to Mar. 2026 (¥238 Mil).

Jinyu Bio-Technology Co's annual Other Current Payables declined from Dec. 2023 (¥335 Mil) to Dec. 2024 (¥237 Mil) but then increased from Dec. 2024 (¥237 Mil) to Dec. 2025 (¥335 Mil).

Jinyu Bio-Technology Co Other Current Payables Related Terms

Jinyu Bio-Technology Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Jinyu Bio-Technology Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinyu Bio-Technology Co Other Current Payables Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 201.88 127.82 335.17 237.36 335.24

Jinyu Bio-Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 203.63 313.82 316.74 335.24 238.31
SHSE:600201
65GF Score
Jinyu Bio-Technology Co Ltd SHSE:600201
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinyu Bio-Technology Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ¥238 Mil mean?
Jinyu Bio-Technology Co (SHSE:600201) has a Other Current Payables of ¥238 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jinyu Bio-Technology Co and its competitors.
Is Jinyu Bio-Technology Co's Other Current Payables too high?
Jinyu Bio-Technology Co's current Other Current Payables is ¥238 Mil. Overall, Jinyu Bio-Technology Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Other Current Payables compare to VRTX and REGN?
Jinyu Bio-Technology Co's Other Current Payables of ¥238 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jinyu Bio-Technology Co and its competitors. Jinyu Bio-Technology Co's current Other Current Payables is ¥238 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.34, compared to a current price of ¥11.30 — trading 35.5% above its estimated fair value. The current Other Current Payables is ¥238 Mil. Jinyu Bio-Technology Co's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Other Current Payables is ¥238 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?

Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥11.30 is trading 35.5% above its estimated GF Value™ of ¥8.34. GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600201:

  • Other Current Payables: ¥238 Mil
  • GF Value™: ¥8.34 vs. price of ¥11.30 (35.5% above fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jinyu Bio-Technology Co Business Description

Address No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
65GF Score

Get the complete analysis for SHSE:600201

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.30
Price
¥8.34
GF Value